Paclitaxel 30 mg/5ml injection
Product Overview
Paclitaxel Kabi 6 mg/ml Solution for injection is an advanced antineoplastic agent specifically formulated for intravenous administration.
It belongs to the taxane class of drugs, widely recognized for its efficacy in treating various types of cancer.
This potent chemotherapy medication works by interfering with the growth and division of cancer cells.
It is manufactured by Fresenius Kabi, a global leader in pharmaceutical products.
Benefits of Use
Paclitaxel Kabi offers significant therapeutic benefits in the management of several cancers:
- Effective treatment for ovarian cancer, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
- Works by stabilizing microtubules, leading to inhibition of cell division and induction of apoptosis in cancer cells.
- Provides a targeted approach to chemotherapy, disrupting tumor growth and progression.
- Administered under strict medical supervision to maximize therapeutic outcomes and manage potential side effects.
How to Use
Paclitaxel Kabi is a prescription medication and must be administered by a qualified healthcare professional.
- The solution is typically diluted before use and administered as an intravenous infusion.
- Dosage and administration schedule are determined by the physician based on the patient's medical condition, type of cancer, body surface area, and response to treatment.
- Close monitoring of vital signs and adverse reactions is essential during and after infusion.
- Patients should be pre-medicated to prevent hypersensitivity reactions before Paclitaxel administration.
Caution & Warnings
- Paclitaxel Kabi can cause severe hypersensitivity reactions, including anaphylaxis.
- Bone marrow suppression (neutropenia, anemia, thrombocytopenia) is a common dose-limiting toxicity; regular blood counts are necessary.
- Peripheral neuropathy, myalgia, arthralgia, and alopecia are common side effects.
- Use with extreme caution in patients with hepatic impairment.
- Not recommended for use during pregnancy or breastfeeding due to potential fetal harm. Effective contraception is advised.
- Avoid concomitant use with strong CYP2C8 and CYP3A4 inhibitors/inducers without medical consultation.
- Keep out of reach of children.
- Strictly for hospital or clinic use under oncology specialist supervision.
Ingredients
- Active Ingredient: Paclitaxel 6 mg/ml
- Inactive Ingredients: Typically includes Cremophor EL (polyoxyethylated castor oil) and dehydrated ethanol.
Product Details
- Concentration: 6 mg/ml
- Volume: 5ml per vial
- Form: Solution for injection
- Manufacturer: Fresenius Kabi
- Drug Type: Prescription Only Medicine (POM)
| Gtin | 08901038839926 |
|---|---|
| Recommended Sale Price | 162.8 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | PACLITAXEL |
| SFDA Reg. No | 603257006 |
| IBC | 08901038839926 |
| Drug Type | Prescription |
| Scientific Name | Paclitaxel |
| Strength | 6 |
| Strength Unit | mg/ml |
| Form | Solution for injection |
| Admin Route | Intravenous |
| Size | 5 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 5ml |
| Storage conditions | Store below 25°C, protected from light |

